You may also be interested in...
NICE publishes new rapid guideline to diagnose and treat rare blood clotting condition associated with COVID-19 vaccination
NICE has today published a new rapid COVID-19 guideline to help healthcare staff identify and treat patients who develop the rare syndrome vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving COVID-19 vaccinations.
Amanda Pritchard has been appointed as the next NHS England chief executive.
In a change to current practice the guideline says that the first-line choice of antibiotic for adults for a first episode of mild or moderate C. difficile infection should be oral vancomycin, rather than metronidazole.